The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

South Africa's new maternity care guidelines address a critical gap by recognising maternal mental health, yet implementation ...

Encephalitis survivors experience hidden mental health struggles and there is an urgent need for improved support within the ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage ...

The Semmelweis reflex occurs when novel ideas are rejected because they challenge existing beliefs. Read on to see how this relates to low-dose ketamine treatment for depression.

An experimental treatment for depression that triggers seizures with magnets significantly improved mental health in patients ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ma ...

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...